KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Treasury Shares (2019 - 2025)

Ginkgo Bioworks Holdings filings provide 7 years of Treasury Shares readings, the most recent being $4.4 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 32.45% to $4.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.4 million, a 32.45% increase, with the full-year FY2025 number at $4.4 million, up 32.45% from a year prior.
  • Treasury Shares hit $4.4 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $1.9 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $238.7 million in Q1 2024 to a low of $137990.0 in Q1 2022.
  • Median Treasury Shares over the past 5 years was $13.7 million (2024), compared with a mean of $79.2 million.
  • Biggest five-year swings in Treasury Shares: surged 142742.23% in 2023 and later crashed 99.67% in 2024.
  • Ginkgo Bioworks Holdings' Treasury Shares stood at $27.9 million in 2021, then soared by 382.49% to $134.4 million in 2022, then crashed by 97.17% to $3.8 million in 2023, then dropped by 12.55% to $3.3 million in 2024, then surged by 32.45% to $4.4 million in 2025.
  • The last three reported values for Treasury Shares were $4.4 million (Q4 2025), $1.9 million (Q3 2025), and $5.0 million (Q2 2025) per Business Quant data.